Relapsed/Refractory Pediatric B-ALL
1 clinical trials · Condition
◉ Watch Relapsed/Refractory Pediatric B-ALL
| Record | Firm | Date |
|---|---|---|
| JY509 Universal NK Cell Injection for the Treatment of Relapsed/Refractory Pediatric B-ALL (NCT07406178) | Institute of Hematology & Blood Diseases Hospital, China | 2026-01-20 |
Track Relapsed/Refractory Pediatric B-ALL automatically
Every clearance here is in the API, with alerts when new ones post.